Damon (Feng) Wang
Co-Founder, Nucyrna Therapeutics
Former RTI Lab: PhD Candidate, Watts Lab
Training Period: 2019-2023
Prior Academic Degree Institution: Northwest A&F University
Damon obtained his BS in biotechnology at Northwest A&F University in China in 2015. He then moved to Hong Kong as a research assistant working on homology independent genome editing. Damon is a PhD candidate working on RNA therapeutics for neurological diseases such as Friedreich's Ataxia and has been following the RNA therapeutics market tightly. The best way to alter Damon's whole body transcriptome into a happier stage is by grabbing some bourbon whiskey in a classy jazz bar, where neither a gRNA library nor small molecule library is needed.